IL158418A0
(en)
*
|
2001-04-19 |
2004-05-12 |
Scripps Research Inst |
In vivo incorporation of unnatural amino acids
|
ATE445709T1
(de)
*
|
2002-10-16 |
2009-10-15 |
Scripps Research Inst |
Glycoproteinsynthese
|
ATE542894T1
(de)
|
2003-04-17 |
2012-02-15 |
Scripps Research Inst |
Ausweitung des eukaryotischen genetischen codes
|
CA2527877A1
(en)
|
2003-06-18 |
2005-01-13 |
The Scripps Research Institute |
Unnatural reactive amino acid genetic code additions
|
DE602004027770D1
(de)
|
2003-07-07 |
2010-07-29 |
Scripps Research Inst |
Zusammensetzungen aus orthogonalen Lysyl-TRNA- und Aminoacyl-TRNA-Synthetasepaaren und deren Verwendung
|
EP1687401B1
(en)
|
2003-10-14 |
2012-11-21 |
The Scripps Research Institute |
Site-specific incorporation of redox active amino acids into proteins
|
JP4896745B2
(ja)
|
2004-02-02 |
2012-03-14 |
アンブレツクス・インコーポレイテツド |
修飾されたヒトインターフェロンポリペプチドおよびこれらの使用
|
EP1774018A2
(en)
|
2004-05-25 |
2007-04-18 |
The Scripps Research Institute |
Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination
|
AU2005265163B2
(en)
|
2004-06-18 |
2009-10-01 |
Ambrx, Inc. |
Novel antigen-binding polypeptides and their uses
|
JP2008513039A
(ja)
|
2004-09-21 |
2008-05-01 |
ザ スクリップス リサーチ インスティテュート |
真正細菌の蛋白質へのアルキニルアミノ酸のインビボ組込み
|
JP2008513806A
(ja)
*
|
2004-09-22 |
2008-05-01 |
ザ スクリップス リサーチ インスティテュート |
Nmr試験のための蛋白質の部位特異的標識
|
US7378263B2
(en)
|
2004-10-20 |
2008-05-27 |
The Scripps Research Institute |
In vivo site-specific incorporation of N-acetyl-galactosamine amino acids in eubacteria
|
MX2007004892A
(es)
|
2004-10-27 |
2007-08-16 |
Scripps Research Inst |
Componentes de traduccion ortogonales para la incorporacion in vivo de aminoacidos no naturales.
|
US7816320B2
(en)
|
2004-12-22 |
2010-10-19 |
Ambrx, Inc. |
Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35
|
CN101087875B
(zh)
|
2004-12-22 |
2012-08-22 |
Ambrx公司 |
氨酰基-tRNA合成酶的组合物及其用途
|
US8080391B2
(en)
|
2004-12-22 |
2011-12-20 |
Ambrx, Inc. |
Process of producing non-naturally encoded amino acid containing high conjugated to a water soluble polymer
|
CN103690936A
(zh)
|
2004-12-22 |
2014-04-02 |
Ambrx公司 |
经修饰的人类生长激素
|
SG165353A1
(en)
|
2005-06-03 |
2010-10-28 |
Ambrx Inc |
Improved human interferon molecules and their uses
|
CA2624290A1
(en)
*
|
2005-10-12 |
2007-04-26 |
Scripps Research Institute |
Selective posttranslational modification of phage-displayed polypeptides
|
PT2339014E
(pt)
|
2005-11-16 |
2015-10-13 |
Ambrx Inc |
Métodos e composições compreendendo aminoácidos não-naturais
|
CN101365807A
(zh)
|
2005-12-22 |
2009-02-11 |
加利福尼亚太平洋生物科学股份有限公司 |
用于掺入核苷酸类似物的聚合酶
|
MX2008011470A
(es)
*
|
2006-03-09 |
2008-09-24 |
Scripps Research Inst |
Sistemas para la expresion de componentes de traduccion ortogonales en celulas huesped eubacterianas.
|
US8217145B2
(en)
|
2006-03-16 |
2012-07-10 |
The Scrips Research Institute |
Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
|
CA2652894A1
(en)
*
|
2006-05-23 |
2007-12-06 |
The Scripps Research Institute |
Genetically encoded fluorescent coumarin amino acids
|
ES2465473T3
(es)
|
2006-09-08 |
2014-06-05 |
Ambrx, Inc. |
Transcripción de arnt supresor en células de vertebrado
|
JP5840345B2
(ja)
|
2006-09-08 |
2016-01-06 |
アンブルックス, インコーポレイテッドAmbrx, Inc. |
修飾ヒト血漿ポリペプチドまたは修飾ヒトFc足場タンパク質ならびにこれらの利用
|
WO2008036392A2
(en)
*
|
2006-09-21 |
2008-03-27 |
The Scripps Research Institute |
Genetically programmed expression of selectively sulfated proteins in eubacteria
|
KR20090094812A
(ko)
|
2006-10-18 |
2009-09-08 |
더 스크립스 리서치 인스티튜트 |
포유동물 세포에서 비천연 아미노산의 단백질 내로의 유전적 도입
|
ATE554785T1
(de)
|
2007-03-30 |
2012-05-15 |
Ambrx Inc |
Modifizierte fgf-21 polypeptide und ihre verwendung
|
JP2010525821A
(ja)
|
2007-05-02 |
2010-07-29 |
アンブルックス,インコーポレイテッド |
修飾IFNβポリペプチドおよびこれらの使用
|
EP2217707B1
(en)
*
|
2007-10-25 |
2014-10-15 |
The Scripps Research Institute |
Genetic incorporation of 3-aminotyrosine into reductases
|
BRPI0819092A2
(pt)
*
|
2007-11-02 |
2014-10-14 |
Scripps Research Inst |
Evolução direcionada usando proteínas que compreendem aminoácidos não naturais.
|
WO2009059056A2
(en)
*
|
2007-11-02 |
2009-05-07 |
The Scripps Research Institute |
A genetically encoded boronate amino acid
|
DK2217265T3
(en)
|
2007-11-20 |
2017-07-03 |
Ambrx Inc |
Modified insulin polypeptides and their use
|
KR20100105846A
(ko)
|
2007-12-11 |
2010-09-30 |
더 스크립스 리서치 인스티튜트 |
메틸영양요구성 효모 피키아 파스토리스에서의 생체 내 비천연 아미노산 발현
|
US20110052525A1
(en)
*
|
2008-02-08 |
2011-03-03 |
The Scripps Research Institute |
Breaking Immunological Tolerance with a Genetically Encoded Unnatural Amino Acid
|
EP2247743B1
(en)
|
2008-02-08 |
2016-04-06 |
Ambrx, Inc. |
Modified leptin polypeptides and their uses
|
WO2009151491A2
(en)
*
|
2008-02-27 |
2009-12-17 |
The Scripps Research Institute |
In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group
|
EP2942404B1
(en)
|
2008-03-31 |
2016-11-23 |
Pacific Biosciences of California, Inc. |
Generation of modified polymerases for improved accuracy in single molecule sequencing
|
BRPI0916515B8
(pt)
|
2008-07-23 |
2021-07-27 |
Ambrx Inc |
polipeptídeo de fator estimulante de colônias de granulócitos bovino (bg-csf), formulação farmacêutica e composição compreendendo o mesmo
|
BRPI0919031A2
(pt)
|
2008-09-26 |
2014-09-23 |
Ambrx Inc |
Micro-organismos e vacinas dependentes de replicação através do uso de aminoácidos não naturais
|
MX346001B
(es)
|
2008-09-26 |
2017-03-01 |
Ambrx Inc |
Polipeptidos de eritropoyetina animal modificados y sus usos.
|
US20090197339A1
(en)
*
|
2008-12-10 |
2009-08-06 |
The Scripps Research Institute |
In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris
|
US8609383B2
(en)
|
2008-12-10 |
2013-12-17 |
The Scripps Research Institute |
Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
|
CN102753573A
(zh)
|
2009-12-21 |
2012-10-24 |
Ambrx公司 |
经过修饰的牛促生长素多肽和其用途
|
AU2010341518B2
(en)
|
2009-12-21 |
2014-01-09 |
Ambrx, Inc. |
Modified porcine somatotropin polypeptides and their uses
|
EP2563380B1
(en)
|
2010-04-26 |
2018-05-30 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
|
EP2563381B1
(en)
|
2010-04-27 |
2017-08-09 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
|
EP2563382B1
(en)
|
2010-04-27 |
2017-06-07 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases
|
WO2011139853A2
(en)
|
2010-04-28 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
|
CA2797393C
(en)
|
2010-04-29 |
2020-03-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
|
CA2797374C
(en)
|
2010-04-29 |
2021-02-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
|
US9034321B2
(en)
|
2010-05-03 |
2015-05-19 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
|
JP5976638B2
(ja)
|
2010-05-03 |
2016-08-23 |
エータイアー ファーマ, インコーポレイテッド |
アルギニルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
JP6039546B2
(ja)
|
2010-05-03 |
2016-12-07 |
エータイアー ファーマ, インコーポレイテッド |
セリルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
EP2566496B1
(en)
|
2010-05-03 |
2018-02-28 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
|
CN103096909A
(zh)
|
2010-05-04 |
2013-05-08 |
Atyr医药公司 |
与谷氨酰-脯氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
EP2566499B1
(en)
|
2010-05-04 |
2017-01-25 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
|
US8945541B2
(en)
|
2010-05-14 |
2015-02-03 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
|
JP6027965B2
(ja)
|
2010-05-17 |
2016-11-16 |
エータイアー ファーマ, インコーポレイテッド |
ロイシルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
EP2575856B1
(en)
|
2010-05-27 |
2017-08-16 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
|
EP2575857B1
(en)
|
2010-06-01 |
2018-01-24 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
|
US8999321B2
(en)
|
2010-07-12 |
2015-04-07 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
|
WO2012021249A2
(en)
|
2010-07-12 |
2012-02-16 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
|
WO2012009289A2
(en)
|
2010-07-12 |
2012-01-19 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
|
WO2012021247A2
(en)
|
2010-07-12 |
2012-02-16 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
|
EP4302783A3
(en)
|
2010-08-17 |
2024-03-13 |
Ambrx, Inc. |
Modified relaxin polypeptides and their uses
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
AU2011293294B2
(en)
|
2010-08-25 |
2016-03-24 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Tyrosyl-tRNA synthetases
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
EP2624857B1
(en)
|
2010-10-06 |
2017-08-02 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tryptophanyl trna synthetases
|
US20130078671A1
(en)
*
|
2011-03-25 |
2013-03-28 |
The Texas A&M University System |
Incorporation of two different noncanonical amino acids into a single protein
|
US9714419B2
(en)
|
2011-08-09 |
2017-07-25 |
Atyr Pharma, Inc. |
PEGylated tyrosyl-tRNA synthetase polypeptides
|
US9816084B2
(en)
|
2011-12-06 |
2017-11-14 |
Atyr Pharma, Inc. |
Aspartyl-tRNA synthetases
|
WO2013086228A1
(en)
|
2011-12-06 |
2013-06-13 |
Atyr Pharma, Inc. |
Pegylated aspartyl-trna synthetase polypeptides
|
CN102517241B
(zh)
*
|
2011-12-19 |
2013-06-19 |
中国药科大学 |
一种含有d型氨基酸的双羰基还原酶的突变体的制备方法
|
CN104220461A
(zh)
|
2011-12-29 |
2014-12-17 |
Atyr医药公司 |
天冬氨酰-tRNA合成酶-FC缀合物
|
WO2013171485A1
(en)
*
|
2012-05-18 |
2013-11-21 |
Medical Research Council |
Methods of incorporating an amino acid comprising a bcn group into a polypeptide using an orthogonal codon encoding it and an orthorgonal pylrs synthase.
|
JO3564B1
(ar)
|
2013-03-08 |
2020-07-05 |
Novartis Ag |
ببتيدات وتركيبات لعلاج ضرر المفاصل
|
CN105378075B
(zh)
|
2013-03-15 |
2022-04-05 |
Atyr 医药公司 |
组氨酰-trna合成酶-fc缀合物
|
CN104099360A
(zh)
*
|
2013-04-12 |
2014-10-15 |
北京大学 |
非天然氨基酸标记的目的蛋白或肽的制备
|
US10005838B2
(en)
|
2013-07-19 |
2018-06-26 |
The Regents Of The University Of California |
Milk fat globule epidermal growth factor 8 regulates fatty acid uptake
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
US9737604B2
(en)
|
2013-09-06 |
2017-08-22 |
President And Fellows Of Harvard College |
Use of cationic lipids to deliver CAS9
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
US9340800B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
Extended DNA-sensing GRNAS
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
US10077453B2
(en)
|
2014-07-30 |
2018-09-18 |
President And Fellows Of Harvard College |
CAS9 proteins including ligand-dependent inteins
|
PT3412302T
(pt)
|
2014-10-24 |
2021-06-09 |
Bristol Myers Squibb Co |
Polipéptidos de fgf-21 modificados e utilizações dos mesmos
|
GEP20227438B
(en)
|
2015-07-30 |
2022-11-10 |
Macrogenics Inc |
Pd-1-binding molecules and methods of use thereof
|
JP7067793B2
(ja)
|
2015-10-23 |
2022-05-16 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
核酸塩基編集因子およびその使用
|
EP3389714A4
(en)
|
2015-12-14 |
2019-11-13 |
MacroGenics, Inc. |
BISPECIFIC MOLECULES HAVING IMMUNOREACTIVITY TO PD-1 AND CTLA-4 AND METHODS OF USE
|
JP7231935B2
(ja)
|
2016-08-03 |
2023-03-08 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
アデノシン核酸塩基編集因子およびそれらの使用
|
AU2017308889B2
(en)
|
2016-08-09 |
2023-11-09 |
President And Fellows Of Harvard College |
Programmable Cas9-recombinase fusion proteins and uses thereof
|
US11542509B2
(en)
|
2016-08-24 |
2023-01-03 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
KR20240007715A
(ko)
|
2016-10-14 |
2024-01-16 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵염기 에디터의 aav 전달
|
MX2019005621A
(es)
|
2016-11-14 |
2019-08-12 |
Novartis Ag |
Metodos y composiciones para el tratamiento del daño del cartilago y la artritis.
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
TW201837051A
(zh)
|
2017-02-08 |
2018-10-16 |
美商必治妥美雅史谷比公司 |
包含藥物動力學增強劑之經修飾之鬆弛素(relaxin)多肽及其用途
|
US11898179B2
(en)
|
2017-03-09 |
2024-02-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
EP3592777A1
(en)
|
2017-03-10 |
2020-01-15 |
President and Fellows of Harvard College |
Cytosine to guanine base editor
|
KR20190130613A
(ko)
|
2017-03-23 |
2019-11-22 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
|
EP3612215A4
(en)
|
2017-04-20 |
2021-05-26 |
aTyr Pharma, Inc. |
COMPOSITIONS AND METHODS OF TREATMENT OF Pneumonia
|
WO2018209320A1
(en)
|
2017-05-12 |
2018-11-15 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
|
JP2020534795A
(ja)
|
2017-07-28 |
2020-12-03 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ファージによって支援される連続的進化(pace)を用いて塩基編集因子を進化させるための方法および組成物
|
WO2019139645A2
(en)
|
2017-08-30 |
2019-07-18 |
President And Fellows Of Harvard College |
High efficiency base editors comprising gam
|
WO2019079347A1
(en)
|
2017-10-16 |
2019-04-25 |
The Broad Institute, Inc. |
USES OF BASIC EDITORS ADENOSINE
|
LU100734B1
(en)
|
2018-03-15 |
2019-10-01 |
Univ Hamburg |
Synthetic transfer RNA with extended anticodon loop
|
US11434485B2
(en)
|
2018-03-15 |
2022-09-06 |
Arcturus Therapeutics, Inc. |
Synthetic transfer RNA with extended anticodon loop
|
WO2019191244A1
(en)
|
2018-03-27 |
2019-10-03 |
Scp Holdings, Llc. |
Hot surface igniters for cooktops
|
US20210108213A1
(en)
|
2018-05-01 |
2021-04-15 |
Ambrx, Inc. |
A method for optimizing antibody expression
|
AU2019337610A1
(en)
|
2018-09-11 |
2021-05-06 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and their uses
|
JP2022512746A
(ja)
|
2018-10-19 |
2022-02-07 |
アンブルックス,インコーポレイテッド |
インターロイキン-10ポリペプチド複合体、その二量体、およびそれらの使用
|
EP3942040A1
(en)
|
2019-03-19 |
2022-01-26 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
CN111718920B
(zh)
*
|
2019-03-19 |
2021-05-07 |
宁波鲲鹏生物科技有限公司 |
在蛋白中高效引入赖氨酸衍生物的氨酰基-tRNA合成酶
|
AU2020273255A1
(en)
|
2019-04-11 |
2021-10-28 |
Arcturus Therapeutics, Inc. |
Synthetic transfer RNA with extended anticodon loop
|
LU101182B1
(en)
*
|
2019-04-11 |
2020-10-12 |
Univ Hamburg |
Synthetic transfer RNA with extended anticodon loop
|
CN110172467B
(zh)
*
|
2019-05-24 |
2021-03-16 |
浙江大学 |
一种利用嵌合设计方法构建正交的氨酰-tRNA合成酶/tRNA体系
|
EP4117732A1
(en)
|
2020-03-11 |
2023-01-18 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and methods of use thereof
|
WO2021226558A1
(en)
|
2020-05-08 |
2021-11-11 |
The Broad Institute, Inc. |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
CN114250243B
(zh)
*
|
2020-09-24 |
2024-05-03 |
深圳华大生命科学研究院 |
一种检测极端嗜盐生物中氨酰-tRNA合成酶和tRNA活性的***及方法
|
US20230201365A1
(en)
|
2021-07-09 |
2023-06-29 |
Bright Peak Therapeutics Ag |
Modified cd20 antibodies and uses thereof
|
EP4366782A1
(en)
|
2021-07-09 |
2024-05-15 |
Bright Peak Therapeutics AG |
Conjugates of checkpoint inhibitors with il-2, and uses thereof
|
WO2023281485A1
(en)
|
2021-07-09 |
2023-01-12 |
Bright Peak Therapeutics Ag |
Modified il-2 polypeptides for treatment of inflammatory and autoimmune diseases
|
US20240158537A1
(en)
|
2021-07-09 |
2024-05-16 |
Bright Peak Therapeutics Ag |
Synthetic il-7 and il-7 immunocytokines
|
KR20240040134A
(ko)
|
2021-07-09 |
2024-03-27 |
브라이트 피크 테라퓨틱스 아게 |
항체 접합체 및 이의 제조
|
WO2023069816A2
(en)
|
2021-09-20 |
2023-04-27 |
The Broad Institute, Inc. |
Compositions and methods for multiplex decoding of quadruplet codons
|
US20240132563A1
(en)
|
2022-02-23 |
2024-04-25 |
Bright Peak Therapeutics Ag |
Bifunctional cytokine compositions
|
US20230355795A1
(en)
|
2022-02-23 |
2023-11-09 |
Bright Peak Therapeutics Ag |
Immune antigen specific il-18 immunocytokines and uses thereof
|
CN114908066B
(zh)
*
|
2022-05-17 |
2024-01-23 |
杭州嵌化合生医药科技有限公司 |
一种正交翻译***及其在再分配密码子恢复ptc疾病中功能蛋白表达方面的应用
|
WO2024091824A1
(en)
|
2022-10-26 |
2024-05-02 |
Ada Forsyth Institute, Inc. |
Differentiation and reprogramming of chondrocyte
|
CN115975978B
(zh)
*
|
2023-02-01 |
2023-08-01 |
珠海宝锐生物科技有限公司 |
Bst DNA聚合酶大片段突变体及其应用
|